Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Acer Therapeutics Inc.
Headquarters: Newton, MA, United States of America
Website: N/A
Year Founded: 2013
Status: Acquired
BioCentury | May 23, 2024
Management Tracks
Elias Zerhouni to chair Boston Pharmaceuticals
Plus: SystImmune names Jonathan Cheng CMO, and updates from CRISPR,
BioCentury | May 14, 2024
Management Tracks
Barrett to lead Pulse as CEO
Plus: Anumana hires Harry Palmin as CFO, and new SVP of regulatory at Nanoscope
BioCentury | Jan 5, 2024
Management Tracks
Friedman succeeding Hoos at Scorpion
Plus: 4DMT hires Noriyuki Kasahara as CSO, and updates from SV, Omega, AbbVie Ventures, Nikang, Immunome, Wugen, Zevra and Quris
BioCentury | Jun 22, 2022
Deals
June 21 Quick Takes: Precision, Novartis in gene editing collaboration
Plus Galapagos acquires two companies, BioMarin gains an approval in Japan and updates from Merck & Co., BeiGene, Therorna, Acer and more
BioCentury | Jun 1, 2022
Data Byte
June’s PDUFA dates no longer include Amylyx’s ALS therapy
At least three new therapies and four seeking label extensions have PDUFA goal dates in June
BioCentury | Mar 8, 2022
Deals
March 7 Quick Takes: Clinical hold weighs on Alpine
Plus Xhance meets in sinusitis and updates from Lava, Acer, Maverick and more
BioCentury | Oct 8, 2021
Product Development
Oct. 7 Quick Takes: Early POC data for Bicycle buoys shares
Plus FDA backs Takeda’s maribavir, RA’s $880M fund and updates from AbbVie, Turning Point, EQRx and more
BioCentury | Jul 11, 2020
Management Tracks
Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more
BioCentury | Sep 13, 2019
Company News
Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more
BioCentury | Jun 26, 2019
Company News
June 25 Company Quick Takes: Conatus restructuring; plus Almirall-Dermira, Acer, Glenmark and more
Items per page:
1 - 10 of 17